Pangalos Menelas's most recent trade in Biogen Inc was a trade of 2,370 Common Stock done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | Menelas Pangalos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 2,370 | 2,370 (0%) | 0% | 0 | Common Stock | |
| Biogen | Menelas Pangalos | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 2,370 | 0 | - | - | Restricted Stock Unit | |
| Biogen | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 1,505 | 3,875 (0%) | 0% | 0 | Common Stock | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 39,800 | 39,800 | - | - | Stock Option (right to buy) | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 10,100 | 242,408 | - | 0 | Common Stock | |
| Absci Corp | Menelas Pangalos | Director | Purchase of securities on an exchange or from another person at price $ 5.36 per share. | 13 May 2026 | 37,453 | 232,308 | - | 5.4 | 200,748 | Common Stock |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 22,800 | 22,800 | - | - | Stock Option (right to buy) | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 5,800 | 194,855 | - | 0 | Common Stock | |
| Absci Corp | Menelas Pangalos | Director | Purchase of securities on an exchange or from another person at price $ 2.74 per share. | 27 Feb 2026 | 75,095 | 189,055 | - | 2.7 | 205,760 | Common Stock |
| Absci Corp | Menelas Pangalos | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 22 Sep 2025 | 95,785 | 113,960 | - | 2.7 | 254,788 | Common Stock |
| Biogen | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 2,370 | - | - | Restricted Stock Unit | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 57,400 | 57,400 | - | - | Stock Option (right to buy) | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,500 | 18,175 | - | 0 | Common Stock | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 15,114 | 15,114 | - | - | Stock Option (right to buy) | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 3,675 | 3,675 | - | 0 | Common Stock | |
| Absci Corp | Pangalos Menelas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 106,200 | 106,200 | - | - | Stock Option (right to buy) | |
| Absci Corp | Menelas Pangalos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 18,900 | 18,900 | - | - | Stock Option (right to buy) |